Beyond GLP-1Rs: emerging targets poised to gain share of obesity market – Pharmaceutical Technology
The global landscape for obesity pharmacotherapy is undergoing a profound transformation, with an emerging class of non-glucagon-like peptide-1 receptor (non-GLP-1R)...
June 23, 2025